论文部分内容阅读
目的分析和探讨瘤体大小对经动脉栓塞治疗肝血管瘤的临床疗效的影响。方法38例肝血管瘤患者根据不同栓塞方法分为A、B两组,每组根据瘤体大小分成a,b,c三个小组,所有患者均采用经动脉栓塞,术后2-3个月CT、B超随访观察肿瘤大小变化及并发症。运用SPSS11.5版本统计软件进行数据分析。结果A、B两组病例栓塞术后2-3月瘤体大小缩小程度不同,各小组患者经栓塞后瘤体大小改变通过Kruskal-WallisH检验显示A组各小组组间差异存在统计学意义(P=0.016),B组各治疗组间比较无统计学意义(P=0.546)。结论经肝动脉栓塞治疗肝血管瘤是一种疗效肯定,安全理想的治疗方法,瘤体大小对介入疗效有一定影响,但如果采用恰当的栓塞剂和栓塞方法可避免和减少由于瘤体大小不同对栓塞结果的影响。
Objective To analyze and explore the effect of tumor size on the clinical efficacy of transarterial embolization in the treatment of hepatic hemangiomas. Methods Thirty-eight patients with hepatic hemangiomas were divided into two groups according to different embolization methods. Each group was divided into three groups a, b and c according to the size of the tumor. All patients were treated with arterial embolization and 2-3 months after operation CT and B ultrasound were followed up to observe tumor size changes and complications. Use SPSS11.5 version of the statistical software for data analysis. Results The tumor sizes of groups A and B decreased from February to March after embolization. The changes of tumor size after embolization in each group were statistically significant by Kruskal-Wallis H test (P = 0.016). There was no significant difference between each treatment group in group B (P = 0.546). Conclusion Hepatic hemangioma treated with transcatheter arterial chemoembolization is an effective and safe therapeutic method. The size of the tumor has an impact on the interventional efficacy. However, if the appropriate embolic agent and embolization method can be used to avoid and reduce the size of the tumor, Impact on embolism results.